Biopharma Daily Stock Updates - 04/06/21

$XBI $135 -3%

Covid Updates

$MRNA +3% and $CTLT +1% expand collaboration. source

Pipeline Updates

$FGEN -31% Roxa update. source

$TMDX Halted for FDA adcom. source

$IMAB +5% 1st patient dosed ph 1. source

$GALT +25% launches for patients and physicians. source

$SRRK -20% Ph 2 12-mo data. source

$LABP +8% IND accepted for BT-11. source

$SEEL -7% Partnership with $ATR device for SLS-002. source

$APTX -7% Recommences ph 2 study. source

Finance Updates

$FIXX -14% Offering. source

$SRNE -5% Acquisition of Acea Therapeutics. source

$KDNY -3% Update on non-renal programs from Aduro Bio merger. source


*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.